☰

Michael Shultz - Publications

Affiliations: 
Purdue University, West Lafayette, IN, United States 
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Tommasi RA, Weiler S, Mcquire LW, Rogel O, Chambers M, Clark K, Doughty J, Fang J, Ganu V, Grob J, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, ... ... Shultz M, et al. Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13 Bioorganic and Medicinal Chemistry Letters. 21: 6440-6445. PMID 21937229 DOI: 10.1016/J.Bmcl.2011.08.087  0.308
2011 Shultz M, Fan J, Chen C, Cho YS, Davis N, Bickford S, Buteau K, Cao X, Holmqvist M, Hsu M, Jiang L, Liu G, Lu Q, Patel C, Suresh JR, et al. The design, synthesis and structure-activity relationships of novel isoindoline-based histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21: 4909-12. PMID 21742496 DOI: 10.1016/J.Bmcl.2011.06.015  0.326
2010 Cho YS, Whitehead L, Li J, Chen CHT, Jiang L, Vögtle M, Francotte E, Richert P, Wagner T, Traebert M, Lu Q, Cao X, Dumotier B, Fejzo J, Rajan S, ... ... Shultz M, et al. Conformational refinement of hydroxamate-based histone deacetylase inhibitors and exploration of 3-piperidin-3-ylindole analogues of dacinostat (LAQ824) Journal of Medicinal Chemistry. 53: 2952-2963. PMID 20205394 DOI: 10.1021/Jm100007M  0.367
2010 ZUTSHI R, SHULTZ MD, ULYSSE L, LUTGRING R, BISHOP P, SCHWEITZER B, VOGEL K, FRANCISKOVICH J, WILSON M, CHMIELEWSKI J. ChemInform Abstract: Inhibiting the Dimerization of HIV-1 Protease Cheminform. 29: no-no. DOI: 10.1002/CHIN.199852336  0.715
2004 Shultz MD, Ham YW, Lee SG, Davis DA, Brown C, Chmielewski J. Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach. Journal of the American Chemical Society. 126: 9886-7. PMID 15303839 DOI: 10.1021/Ja048139N  0.821
2003 Zhao L, O'Reilly MK, Shultz MD, Chmielewski J. Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization Bioorganic and Medicinal Chemistry Letters. 13: 1175-1177. PMID 12643937 DOI: 10.1016/S0960-894X(03)00040-4  0.748
2000 Shultz M, Bowman M, Ham Y, Zhao X, Tora G, Chmielewski J. Small-Molecule Inhibitors of HIV-1 Protease Dimerization Derived from Cross-Linked Interfacial Peptides Angewandte Chemie. 112: 2822-2825. DOI: 10.1002/1521-3757(20000804)112:15<2822::Aid-Ange2822>3.0.Co;2-1  0.824
1999 Shultz MD, Chmielewski J. Probing the role of interfacial residues in a dimerization inhibitor of HIV-1 protease Bioorganic and Medicinal Chemistry Letters. 9: 2431-2436. PMID 10476882 DOI: 10.1016/S0960-894X(99)00400-X  0.746
1998 Zutshi R, Shultz MD, Ulysse L, Lutgring R, Bishop P, Schweitzer B, Vogel K, Franciskovich J, Wilson M, Chmielewski J. Inhibiting the Dimerization of HIV-1 Protease Synlett. 1998: 1040-1044. DOI: 10.1055/S-1998-1854  0.617
1997 Zutshi R, Franciskovich J, Shultz M, Schweitzer B, Bishop P, Wilson M, Chmielewski J. Targeting the dimerization interface of HIV-1 protease: Inhibition with cross-linked interfacial peptides Journal of the American Chemical Society. 119: 4841-4845. DOI: 10.1021/Ja962496J  0.778
1997 Shultz MD, Chmielewski J. Hydrophobicity versus activity in crosslinked interfacial peptide inhibitors of HIV-1 protease Tetrahedron Asymmetry. 8: 3881-3886. DOI: 10.1016/S0957-4166(97)00572-7  0.733
Show low-probability matches.